Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
This week saw new research on brain tumour and ovarian cancers, while MPs launched an inquiry into e-cigarettes.
A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.
How is CRISPR genome editing helping harness the power of immunotherapy?